ORGANIGRAM GLOBAL INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
SEC Category Emerging growth company
State of Incorporation Canada (Federal Level)
Country Ontario, Canada
Business Address 1400-145 KING ST. WEST, TORONTO, , M5H 1J8
Mailing Address 1400-145 KING ST. WEST, TORONTO, , M5H 1J8
Phone 506-232-4400
Fiscal Year End 0930
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | February 10, 2026 | View on SEC |
| 6-K Foreign company current report | February 3, 2026 | View on SEC |
| 6-K Foreign company current report | January 28, 2026 | View on SEC |
| 6-K Foreign company current report | December 31, 2025 | View on SEC |
| 40-F Canadian company annual report | December 16, 2025 | View on SEC |
| 6-K Foreign company current report | December 5, 2025 | View on SEC |
| 6-K Foreign company current report | December 4, 2025 | View on SEC |
| 6-K Foreign company current report | November 25, 2025 | View on SEC |
| 6-K Foreign company current report | October 29, 2025 | View on SEC |
| 6-K Foreign company current report | October 21, 2025 | View on SEC |
Annual Reports
40-F December 16, 2025
- Organigram acquired Organic Inc., Motif Labs Ltd., and Collective Project Limited (CPL) to expand product range and enter the U.S. market.
- British American Tobacco (BAT) made a $124.6 million follow-on investment and created the 'Jupiter Pool' for international growth.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.